<DOC>
	<DOCNO>NCT00375843</DOCNO>
	<brief_summary>This study examine brain activity affect antidepressant treatment change brain activity relate treatment response people depression .</brief_summary>
	<brief_title>Brain Activity Changes Treatment Response Depressed People Who Are Receiving Antidepressant Medication</brief_title>
	<detailed_description>Depression serious medical illness characterize persistent sad , anxious , empty mood . Many treatment show relieve depression , include medication behavioral therapy . No single treatment , however , work everyone . Approximately half people treat depression respond first medication try . Studies show people depression show change brain activity within 2 week start treatment , even though symptom change later . People respond treatment , however , exhibit change brain activity . More information need understand different way people depression respond medication . This study examine brain activity affect antidepressant treatment change brain activity relate treatment response people depression . It also determine whether brain test involve study burdensome participant . Individuals interested take part 1-year study first attend one screen visit determine eligibility participation . Before begin treatment , participant electroencephalogram ( EEG ) determine baseline brain activity . Participants receive 12 week treatment escitalopram , antidepressant medication . Study visit hold every 2 3 week phase . At Week 2 visit , participant another EEG . Participants respond escitalopram end treatment phase ask participate 6-month follow-up phase , participant follow personal physician , option continue treatment escitalopram . Follow-up visit hold Months 3 6 . Participants respond escitalopram end treatment phase another EEG , receive 12 week treatment sertraline , another antidepressant medication . Study visit hold every 2 3 week , participant fourth EEG Week 2 . Participants respond sertraline enter 6-month follow-up phase , may continue receive sertraline . Participants improve sertraline receive referral additional care outside study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Currently outpatient nonpsychotic , unipolar major depressive disorder ( MDD ) Score 14 great 17item Hamilton Rating Scale Depression ( HAMD17 ) Antidepressant treatment deem appropriate study clinician Willing use effective form contraception throughout study Mentally legally incapacitate Lifetime history bipolar disorder , schizophrenia , schizoaffective disorder , MDD psychotic feature , dementia Patients currently suffer anorexia nervosa , bulimia nervosa , obsessive compulsive disorder History substance abuse disorder within 6 month prior study entry Current suicidal ideation would make outpatient treatment unsafe Past medication response may make escitalopram sertraline treatment unsafe inappropriate ( e.g. , previous intolerance lack response either medication ) History fail treatment escitalopram ( 40 mg ) sertraline ( 200 mg ) current depressive episode Any medical condition would make treatment escitalopram sertraline medically inadvisable Unstable medical illness Unstable psychiatric illness likely require inpatient treatment within 6 month follow study entry History seizure , brain surgery , skull fracture , significant head trauma , previous abnormal EEG Pregnant plan become pregnant within 12 month follow study entry Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>